Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
CC transcript
ENDOCYTE INC (ECYT) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/14/2019 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
12/31/2018 15-12B Form 15-12B - Securities registration termination [Section 12(b)]:
12/27/2018 EFFECT Form EFFECT - Notice of Effectiveness:
12/21/2018 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/21/2018 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/21/2018 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/21/2018 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/21/2018 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/21/2018 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/21/2018 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/21/2018 POSASR Form POSASR - Post-effective Amendment to an automatic shelf registration statement:
12/21/2018 8-K Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta...
Docs: "Amended and Restated Certificate of Incorporation of Endocyte, Inc., effective December 21, 2018",
"Amended and Restated Bylaws of Endocyte, Inc., effective December 21, 2018",
"Form of Amendment to Change in Control and Severance Agreement"
12/21/2018 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
12/20/2018 POS AM Form POS AM - Post-Effective amendments for registration statement:
12/20/2018 GN Endocyte Stockholders Approve Merger Agreement with Novartis AG
12/17/2018 8-K Other Events
12/12/2018 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
12/03/2018 8-K Other Events
11/16/2018 DEFM14A Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
11/08/2018 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
11/08/2018 10-Q Quarterly Report for the period ended September 30, 2018
11/07/2018 8-K Quarterly results
Docs: "Endocyte Provides Third Quarter 2018 Financial Results and Operational Update"
11/06/2018 DFAN14A Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
11/05/2018 DFAN14A Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
11/01/2018 SC 13D Magnetar Financial LLC reports a 6.4% stake in ENDOCYTE, Inc.
10/31/2018 PREM14A Form PREM14A - Preliminary proxy statements relating to merger or acquisition:
10/19/2018 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
10/18/2018 DFAN14A Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
10/18/2018 DFAN14A Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
10/18/2018 DFAN14A Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
10/18/2018 DFAN14A Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
10/18/2018 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
10/18/2018 8-K Quarterly results
10/18/2018 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy